Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.17 (
lysozyme
)
21,489
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Lysozyme is a major component of airway epithelial secretions, acts as cationic anti-microbial protein for innate immunity. Although
lysozyme
plays an important role in airway defense and is a key component of airway secretions under inflammatory conditions, little is understood about the regulation of its expression and the associated signaling pathway. We wanted to examine whether Phorbol 12-myristate 13-acetate (PMA), one of PKC activators, treatment of the airway epithelial cell line NCI-H292 increases
lysozyme
gene expression. In this study, we sought to determine which signal molecules are involved in PMA-induced
lysozyme
gene expression. We found that PKC and mitogen-activating protein/ERK2 kinase are essential for PMA-induced
lysozyme
expression and also mediate the PMA-induced activation of c-Myb protein. We identified a proximal region of the
lysozyme
promoter essential for promoter activity containing c-Myb transcription factor binding site. Additionally, by site-directed promoter mutagenesis, we identified that c-Myb preferred the
CAA
motif of the -85/-73 region of the
lysozyme
promoter. Finally, we showed that overexpression of c-Myb without PMA treatment increased the
lysozyme
promoter activity and protein expression. From these results, we conclude that PMA induces overexpression of
lysozyme
via ERK1/2 MAP kinase-c-Myb signaling pathways in NCI-H292 cells.
...
PMID:Activation of c-Myb transcription factor is critical for PMA-induced lysozyme expression in airway epithelial cells. 2052 9